Factors contributing to progression of renal disease
Baylis, C.; Blantz, R.C.
International Journal of Artificial Organs 9(3): 153-158
1986
ISSN/ISBN: 0391-3988 PMID: 3733240 Document Number: 276570
Document emailed within 1 workday
Related Documents
Muthusethupathi, M.A.; Shivakumar, S.; Chenthil, K.S. 1985: Progression of renal disease--role of non-immunologic factors Journal of the Association of Physicians of India 33(8): 551-552Kumanyika, S.; Adams-Campbell, L.L. 1991: Obesity, diet, and psychosocial factors contributing to cardiovascular disease in blacks Cardiovascular Clinics 21(3): 47-73
Klahr, S.; Harris, K. 1989: Role of dietary lipids and renal eicosanoids on the progression of renal disease Kidney International. Suppl 27: S27-S31
Kleinknecht, C.; Laouari, D. 1982: Nutritional factors in the progression of experimental renal insufficiency Annales de Pediatrie 29(9): 623-625
Devuyst, O. 2003: Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide? Journal of Nephrology 16(3): 449-452
Sensirivatana, R.; Kingwatanakul, P.; Futrakul, P. 1999: Renal perfusion and disease progression Journal of the Medical Association of Thailand 82(5): 496-505
Finocchiaro, P.; Zoccali, C. 2005: Hyperhomocysteinemia and progression of renal disease Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 22(6): 590-596
Futrakul, N.; Futrakul, P. 2004: Microvascular disease and renal disease progression Journal of the Medical Association of Thailand 87(7): 854-859
Kopyt, N.P. 2005: Slowing progression along the renal disease continuum Journal of the American Osteopathic Association 105(4): 207-215
Yazdani, I. 1994: Progression of chronic renal disease--an update Jpma. Journal of the Pakistan Medical Association 44(12): 290-294
Brenner, B.M.; Mackenzie, H.S. 1997: Nephron mass as a risk factor for progression of renal disease Kidney International. Suppl 63: S124-S127
Dworkin, L.D. 1996: Impact of antihypertensive therapy on progression of experimental renal disease Journal of Human Hypertension 10(10): 663-668
Tassopoulos, N.C.; Papatheodoridis, G.V.; Katsoulidou, A.; Delladetsima, J.K.; Sypsa, V.; Touloumi, G.; Nikandros, M.; Hatzakis, A. 1998: Factors associated with severity and disease progression in chronic hepatitis C Hepato-Gastroenterology 45(23): 1678-1683
Raymond, R.D.; Choi, E.J. 2005: Ultra-rapid aortic stenosis progression in end stage renal disease Medicine and Health Rhode Island 88(2): 51-52
Locatelli, F.; Alberti, D.; Graziani, G.; Buccianti, G.; Redaelli, B.; Giangrande, A.; Marcelli, D.; Francucci, B.M. 1992: Factors affecting chronic renal failure progression: results from a multicentre trial. the Northern Italian Cooperative Study Group Mineral and Electrolyte Metabolism 18(2-5): 295-302
Hirsch, D.J. 1985: Limited-protein diet: a means of delaying the progression of chronic renal disease? Canadian Medical Association Journal 132(8): 913-917
Pierce, H.L.; Stevermer, J.J. 2001: Does losartan (Cozaar) slow the progression of renal disease in patients with type 2 diabetes and nephropathy? Journal of Family Practice 50(12): 1083
Orisio, S.; Zoja, C.; Remuzzi, G. 1993: The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 8(4): 213-217
Scarpioni, R.; Michieletti, E.; Cristinelli, L.; Ugolotti, U.; Scolari, F.; Venturelli, C.; Cancarini, G.; Pecchini, P.; Malberti, F.; Maroldi, R.; Rozzi, G.; Olivetti, L. 2005: Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER) Journal of Nephrology 18(4): 423-428
Bodick, N.; Forette, F.; Hadler, D.; Harvey, R.J.; Leber, P.; McKeith, I.G.; Riekkinen, P.J.; Rossor, M.N.; Scheltens, P.; Shimohama, S.; Spiegel, R.; Tanaka, S.; Thal, L.J.; Urata, Y.; Whitehouse, P.; Wilcock, G. 1997: Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group Alzheimer Disease and Associated Disorders 11 Suppl. 3: 50-53